Pfizer has announced its reorganization strategy with Wyeth. The research operations will be broken into two units: a biotechnology unit led by a Wyeth senior executive, and a pharmaceutical group led by a Pfizer scientist. The plan hopes to smoothly integrate Pfizer and Wyeth … [Read more...] about Pfizer’s Reorg Focuses on Biotech
drug development
Merck Execs See ‘Sage’ as Key Ingredient for Disease Biology
Will Open Source "SAGE" platform lead to more transperency to MERCK's research and clinical trials process?Consumers can only hope. Of course if MERCK corporate lawyers figure out that such an open source platform may lead to a clear chain of custody of the type of … [Read more...] about Merck Execs See ‘Sage’ as Key Ingredient for Disease Biology
Medical Imaging Emerges in Clinical Trials
Medical imaging in clinical trials has gained momentum since the FDA began allowing imaging as part of the evidence in support of a new drug application. The FDA, in an effort to increase new drug approvals, has identified imaging as an important technology for assessing new … [Read more...] about Medical Imaging Emerges in Clinical Trials